BREAKING
Home » Archive by Category "Research" (Page 2)

Lyme vaccine: Valneva completes recruitment for Phase 2 studies

By

Valneva SE, a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, Monday announced that it has completed patient recruitment of the Phase 2 studies for...

Antibiotic-resistant Klebsiella oxytoca spread via washing machines: Study

By

Antibiotic-resistant pathogens can be spread via washing machines. This has been proven by hygienists at the University of Bonn for a children’s hospital in which a Klebsiella oxytoca type was...

Antibiotic resistance cause identified: ‘Bacteria can change form to avoid being detected’ according to researchers

By

Scientists have confirmed for the first time that bacteria can change form to avoid being detected by antibiotics in the human body Studying samples from elderly patients with recurring urinary tract infections,...

Chikungunya: New vaccine technology removes the need for refrigeration and delivers potent results

By

A new type of vaccine that can be stored at warmer temperatures, removing the need for refrigeration, has been developed for mosquito-borne virus Chikungunya in a major advance in vaccine technology....

Norovirus: Vaxart’s oral vaccine met all primary/secondary endpoints in Phase 1b study

By

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced positive topline results from the randomized,...

CMV vaccine: University of Minnesota researcher awarded NIH grant to conduct research studies

By

Nationally, about one baby in 100 is born with cytomegalovirus (CMV), the most common infection that causes birth defects and disabilities in babies in the United States. As National Immunization Awareness...

Herpes: Penn-developed vaccine protected almost all animal subjects exposed to the virus

By

Researchers from the Perelman School of Medicine at the University of Pennsylvania have developed a vaccine to protect against genital herpes. Tested on both mice and guinea pigs, the immunization led...

HHS supports development of investigational Ebola treatment

By

An investigational treatment for Ebola virus disease will receive advanced development support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness...

Chagas disease: Alzheimer’s drug, memantine, shows therapeutic potential in research

By

The drugs currently used to treat Chagas disease, a neglected tropical disease, have serious side effects and limited use in those with chronic disease. Now, researchers have reported in PLOS Neglected...

Yellow fever vaccine in a single dose does not offer lasting protection to all children: Study

By

Yellow fever is a viral infection spread by various species of mosquito and is rife in 34 countries in Africa and 13 in Latin America. Infection may be asymptomatic and go unnoticed or, on the contrary,...